FDA Experience with Medical Countermeasures under the Animal Rule
Open accessThe DOI matches its Crossref record.
Abstract
The Food and Drug Administration issued a final rule in May 2002 to permit the Agency to approve drugs or license biological products on the basis of animal efficacy studies for use in ameliorating or preventing serious or life-threatening conditions caused by exposure to lethal or permanently disabling toxic biological, chemical, radiological, or nuclear substances. Only two drugs were approved in the first nine years of the “Animal Rule” despite massive investment by the federal government since 2001 to stimulate development of medical countermeasures to biological threats. This article therefore examines the Food and Drug Administration reviews made public after approval of those two drugs and the public discussion at the Agency's Anti-Infective Drugs Advisory Committee of one biological product under development under the Animal Rule. Despite the paucity of approved drugs or licensed biological products as medical countermeasures, several investigational drugs have been placed in the National Strategic Stockpile for use as medical countermeasures, if needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Animal models for acute radiation syndrome drug discovery
Singh, V. K., Newman, V. L., Berg, A. N., & MacVittie, T. J. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1023290 · Cited by 139
“Although the search for medical countermeasures (MCMs) was initiated more than six decades ago, no safe and effective MCM for ARS has been approved by the US FDA [10-12].”
BackgroundExtrapolating from animals to humans
Ioannidis, J. P. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004631 · Cited by 124
“In 2002, af er years of deliberation and in response to the rising threat of bioterrorism, the U.S. Food and Drug Administration (FDA) formulated the so-called Animal Rule (10, 11), which of ers the ability to license medical countermeasures for biological, chemical, and radiation threats on the basis of ef ectiveness…”
BackgroundInfluentialMoulder, J. E., Cohen, E. P., Medhora, M., & Fish, B. L. (2022) · Life Sciences in Space Research · doi:10.1016/j.lssr.2022.04.005 · Cited by 8
Metadata
- Authors
- Aebersold, P.
- Venue
- Advances in Preventive Medicine
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 2090-3480 (ISSN-L)
- 2090-3499
- OpenAlex
- W2070371245
- Cited by
- 74
- References
- 0
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.